The U.S. Department of Justice accused the pharmacy of illegally filling millions of prescriptions in the last decade for opioids and other controlled substances.
Indiana lawmakers have discovered this legislative session that performing major financial surgery on multibillion-dollar nonprofit hospital systems is a motley and entangled task.
The former CEO of Edison School of the Arts, who sued the school over defamation after his termination in 2023, has reached a deal with the school to receive a judgment of about $269,000 in his favor.
Developer Monarch Ventures LLC, which has submitted plans to build Skylake Adventure Park on 126 acres of agricultural land, expects the park to attract about 500,000 visitors per year.
Trial data data showed Lilly’s experimental weight-loss pill worked as well as the Ozempic shot, bringing it one step closer to developing a needle-free alternative to injections.
Meta CEO Mark Zuckerberg testified in federal court on Wednesday that he bought Instagram and WhatsApp because he saw value in the companies—not to take out competitors, as the FCC alleges.
The former NFL tight end will serve as the grand marshal for the “Snake Pit,” the infield party that takes place during “The Greatest Spectacle in Racing.”
Trump’s order contains proposals to further lower the cost of insulin, importing more low-cost drugs and streamlining the federal approval process for some drugs.
Attorneys offered only a few tweaks to the sprawling deal announced last year that will clear the way for schools to begin sharing millions in revenue with their athletes.
Sparing electronics was expected to benefit big tech companies like Apple and Samsung and chip makers like Nvidia, though the uncertainty of future tariffs may rein in an anticipated tech stock rally on Monday.
